Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104



Status:Active, not recruiting
Conditions:Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:12/13/2018
Start Date:April 17, 2018
End Date:November 13, 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to assess the long-term safety and tolerability of ABBV-8E12 in
subjects with progressive supranuclear palsy (PSP).


Inclusion Criteria:

- Subject completed Study C2N-8E12-WW-104 (NCT02494024)

- Subject was not eligible to enroll in Study M15-562 (NCT02985879)

Exclusion Criteria:

- Subject weighs less than 35 kg at screening

- Subject has any contraindication or inability to tolerate brain MRI

- Subject has any significant change in his/her medical condition that could interfere
with the subject's participation in the study, could place the subject at increased
risk, or could confound interpretation of study results
We found this trial at
2
sites
Kerwin Research Center /ID# 170112
Dallas, Texas 75218
?
mi
from
Dallas, TX
Click here to add this to my saved trials
University of California, San Diego /ID# 170113
La Jolla, California 92093
?
mi
from
La Jolla, CA
Click here to add this to my saved trials